Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01211535 · ClinicalTrials.gov registry record · NA
Subjective Comfort With Multipurpose Care Solutions in Soft Contact Lens Wearers
A NA study, sponsored by Alcon Research.
- Completed
- Registry status
- NA
- Development phase
- 104
- Enrollment target
NCT01211535: Completed NA study, sponsored by Alcon Research.
NCT01211535 is a NA study that has completed, run by Alcon Research. The registered enrollment target is 104 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01211535, a NA study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 104 participants
- Enrollment target
Study Summary
The purpose of this study was to assess the comfort of OPTI-FREE RepleniSH in soft contact lens wearers.
Primary Outcome
Ocular comfort was rated by the participant on a continuous visual analog scale from 0-100, where 0=extremely uncomfortable, 50=neither comfortable nor uncomfortable, and 100=extremely comfortable. The participant marked a horizontal line across the scale at the point that best described, "how your eyes feel right now." A positive number indicates increased ocular comfort; a negative number indicates decreased ocular comfort.
Interventions
- DEVICE OPTI-FREE RepleniSH multipurpose solution
- DEVICE ReNu Biotrue multipurpose solution
- DEVICE Silicone hydrogel contact lenses
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2010-09 |
| Est. Completion | 2010-11 |
| Phase | NA |
What the finished NCT01211535 record still lists
NCT01211535 is an interventional study that assigns participants to a tested intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 3 interventions - of which OPTI-FREE RepleniSH multipurpose solution is the first listed.
NCT01211535 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01211535 about?
NCT01211535 is a clinical study titled "Subjective Comfort With Multipurpose Care Solutions in Soft Contact Lens Wearers". The purpose of this study was to assess the comfort of OPTI-FREE RepleniSH in soft contact lens wearers.
What is the current status of trial NCT01211535?
This trial is currently completed. It is a NA study. The enrollment target is 104 participants. The study started on 2010-09. Estimated completion is 2010-11.
What interventions are being tested in trial NCT01211535?
The interventions under investigation include: OPTI-FREE RepleniSH multipurpose solution (DEVICE), ReNu Biotrue multipurpose solution (DEVICE), Silicone hydrogel contact lenses (DEVICE).
Who is sponsoring clinical trial NCT01211535?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01211535's enrollment target sits among peer trials
104 836th of 2000 higher than 1,164 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03403686 · 104 participants
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
- NCT04228367 · 104 participants · NA
JuggerStitch Post Market Clinical Follow-up Study
- NCT04268849 · 104 participants · Phase 3
Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
- NCT04390724 · 104 participants
Optimizing Y90 Therapy for Radiation Lobectomy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia